Moreover, c-Myc is often dysregulated and overexpressed in many different tumor types, including leukemia [53,54], and it drives the expression of NKG2DL in a mouse leukemia model [55] and the expression of ULBP1/2/3 in human AML [45]. Here, MYC is linked to leukemia.